Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,085) with videos related to
Page
of 109
Sort By:
Human Mutation
|
September 8, 2006
Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry
J L Bernstein, S Teraoka, M C Southey, et al.
Systematic Reviews
|
January 21, 2019
Effectiveness of stop smoking interventions among adults: protocol for an overview of systematic reviews and an updated systematic review
Mona Hersi, Gregory Traversy, Brett D Thombs, et al.
Human Mutation
|
September 8, 2011
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
Jennifer D Brooks, Sharon N Teraoka, Anne S Reiner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 6, 2019
The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists
Carmen Bergom, Catharine M West, Daniel S Higginson, et al.
Journal of the National Cancer Institute
|
May 19, 2017
Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study
Mark E Robson, Anne S Reiner, Jennifer D Brooks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group
Paul A Meyers, Cindy L Schwartz, Mark D Krailo, et al.
Radiation Research
|
August 17, 2023
Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation Therapy
Gordon P Watt, Susan A Smith, Rebecca M Howell, et al.
Cell Death and Differentiation
|
May 14, 2016
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
K Newton, D L Dugger, A Maltzman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2012
Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study
Anne S Reiner, Esther M John, Jennifer D Brooks, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2012
Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies
E V Kane, E Roman, N Becker, et al.
Page
of 109
Search research articles
Search
Showing results (1011-1020 of 1,085) with videos related to
Sort By:
Page
of 109
Human Mutation
|
September 8, 2006
Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry
J L Bernstein, S Teraoka, M C Southey, et al.
Systematic Reviews
|
January 21, 2019
Effectiveness of stop smoking interventions among adults: protocol for an overview of systematic reviews and an updated systematic review
Mona Hersi, Gregory Traversy, Brett D Thombs, et al.
Human Mutation
|
September 8, 2011
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
Jennifer D Brooks, Sharon N Teraoka, Anne S Reiner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 6, 2019
The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists
Carmen Bergom, Catharine M West, Daniel S Higginson, et al.
Journal of the National Cancer Institute
|
May 19, 2017
Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study
Mark E Robson, Anne S Reiner, Jennifer D Brooks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group
Paul A Meyers, Cindy L Schwartz, Mark D Krailo, et al.
Radiation Research
|
August 17, 2023
Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation Therapy
Gordon P Watt, Susan A Smith, Rebecca M Howell, et al.
Cell Death and Differentiation
|
May 14, 2016
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
K Newton, D L Dugger, A Maltzman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2012
Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study
Anne S Reiner, Esther M John, Jennifer D Brooks, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2012
Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies
E V Kane, E Roman, N Becker, et al.
Page
of 109